PubRank

Wenhui Lou

Author PubWeight™ 15.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From Controls: A Multicenter Study. Ann Surg 2016 1.66
2 Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells. Tumour Biol 2013 1.34
3 Granulocytic sarcoma of the pancreas: a case report and review of the literatures. BMC Gastroenterol 2010 0.97
4 Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis. Cancer Sci 2009 0.93
5 A phase I pilot trial of MUC1-peptide-pulsed dendritic cells in the treatment of advanced pancreatic cancer. Clin Exp Med 2011 0.92
6 Effect of CCR7, CXCR4 and VEGF-C on the lymph node metastasis of human pancreatic ductal adenocarcinoma. Oncol Lett 2013 0.91
7 Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2. BMC Gastroenterol 2010 0.88
8 Induction of protective and therapeutic anti-pancreatic cancer immunity using a reconstructed MUC1 DNA vaccine. BMC Cancer 2009 0.86
9 TRAF6 is over-expressed in pancreatic cancer and promotes the tumorigenicity of pancreatic cancer cells. Med Oncol 2014 0.82
10 IRF-2 is over-expressed in pancreatic cancer and promotes the growth of pancreatic cancer cells. Tumour Biol 2011 0.82
11 Expression of CK19 and KIT in resectable pancreatic neuroendocrine tumors. Tumour Biol 2013 0.82
12 Expression of PTEN and mTOR in pancreatic neuroendocrine tumors. Tumour Biol 2013 0.81
13 Clinicopathological characteristics and prognosis-related factors of resectable pancreatic neuroendocrine tumors: a retrospective study of 104 cases in a single Chinese center. Pancreas 2014 0.79
14 Association between cytochrome P450 2C9 gene polymorphisms and colorectal cancer susceptibility: evidence from 16 case-control studies. Tumour Biol 2014 0.76
15 Clinical Analysis and Comprehensive Treatment of Nonfunctional Pancreatic Neuroendocrine Tumor With Liver Metastases: A Retrospective Single-Center Study. Pancreas 2015 0.76
16 The value of serum chromogranin A as a predictor of tumor burden, therapeutic response, and nomogram-based survival in well-moderate nonfunctional pancreatic neuroendocrine tumors with liver metastases. Eur J Gastroenterol Hepatol 2015 0.76
17 Prognostic value of histological subtype in intraductal papillary mucinous neoplasm of the pancreas: A retrospective analysis of outcome from one single center. Medicine (Baltimore) 2017 0.75
18 IL-8-Positive Tumor-Infiltrating Inflammatory Cells Are a Novel Prognostic Marker in Pancreatic Ductal Adenocarcinoma Patients. Pancreas 2016 0.75
19 One Hundred Twenty-One Resected Solid Pseudopapillary Tumor of the Pancreas: An 8-Year Single-Institution Experience at Zhongshan Hospital, Shanghai, China. Pancreas 2017 0.75
20 DNA-PKcs deficiency sensitizes the human hepatoma HepG2 cells to cisplatin and 5-fluorouracil through suppression of the PI3K/Akt/NF-κB pathway. Mol Cell Biochem 2014 0.75